SubCutaneous (SC) Versus Intravenous (IV) Granulocyte Colony Stimulating Factors (G-CSF) for the Treatment of Neutropenia in Hospitalized Haemato-oncological Patients

NCT01222819 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

120

Enrollment

OTHER

Sponsor class

Stopped Physycians' refusal to continue the study

Conditions

Leukemia

Interventions

DRUG: filgrastim

Sponsor

Rabin Medical Center